Skip to content

Wednesday, October 28, 2026

Data from SEC filings, checked daily

Public filings, plainly told

About Method Sources Newsletter

Insider tradingForm 4

Xeris Biopharma Holdings, Inc. (XERS) Insider Trading

7 open-market trades reported since Sep 1, 2026: 0 purchases worth $0 and 7 sales worth $906K.

By insider

Insider	Role	Buys	Bought	Sells	Sold	Latest
Beth Hecht	See Remarks	0	$0	2	$298K	Oct 2, 2026
Kevin McCulloch	See Remarks	0	$0	3	$518K	Oct 2, 2026
Steven Pieper	See Remarks	0	$0	2	$90K	Oct 2, 2026

All trades

XERS insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	3 mo. after	Filing
Oct 2	Oct 1	Beth HechtSee Remarks	See Remarks	▼ SELL10b5-1	16,666	9.41	$157K	−1.5%		Form 4 ↗
Oct 2	Oct 1	Kevin McCullochSee Remarks	See Remarks	▼ SELL10b5-1	15,000	9.41	$141K	−0.9%		Form 4 ↗
Oct 2	Oct 1	Steven PieperSee Remarks	See Remarks	▼ SELL10b5-1	5,000	9.41	$47K	−0.4%		Form 4 ↗
Sep 29	Sep 28	Kevin McCullochSee Remarks	See Remarks	▼ SELL10b5-1	25,000	10.00	$250K	−1.5%		Form 4 ↗
Sep 1	Sep 1	Beth HechtSee Remarks	See Remarks	▼ SELL10b5-1	16,666	8.49	$141K	−1.5%		Form 4 ↗
Sep 1	Sep 1	Kevin McCullochSee Remarks	See Remarks	▼ SELL10b5-1	15,000	8.49	$127K	−0.9%		Form 4 ↗
Sep 1	Sep 1	Steven PieperSee Remarks	See Remarks	▼ SELL10b5-1	5,000	8.50	$43K	−0.4%		Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings